Herd David, Anderson Brian J
Department of Paediatrics, Starship Children's Hospital, Auckland, New Zealand.
Paediatr Anaesth. 2007 Jul;17(7):622-9. doi: 10.1111/j.1460-9592.2006.02145.x.
The aim of this study was to describe ketamine pharmacokinetics in children to simulate time-concentration profiles to predict duration of concentrations associated with anesthesia, arousal and analgesia.
Children presenting for painful procedures in the Emergency Dept were given ketamine 1-1.5 mgxkg(-1) i.v. Blood was assayed for ketamine on 3-6 occasions (median 3) over the subsequent 14-152 min (median 28.5). A population pharmacokinetic analysis was undertaken by using nonlinear mixed effects models (NONMEM). Simulation was used to predict time-concentration profiles in this cohort
There were 188 observations from 54 children (age 8.3 sd 3.5 years, weight 32.5 sd 15.6 kg). A two-compartment (central, peripheral) linear disposition model fitted data better than a one-compartment model. Population parameter estimates and their between subject variability (BSV), standardized to a 70-kg person using allometric models, were central volume (V1) 38.7 (BSV 64%) l.70 kg(-1), peripheral volume of distribution (V2) 102 (51.7%) l.70 kg(-1), clearance (CL) 90 (38.1%) l.h(-1) 70 kg(-1) and intercompartment clearance (Q) 215 (19%) l.h(-1) 70 kg(-1). At 10 min half of the children given 1 mgxkg(-1) will have a serum concentration below 0.75 mgxl(-1). This is a concentration associated with 'awakening' in adults. However, almost all the children will still have a serum concentration above 0.1 mgxl(-1), a level associated with analgesia in adults.
Ketamine 1 mgxkg(-1) i.v. provides satisfactory serum concentrations for children undergoing sedation for painful procedures of <5-min duration and produces concentrations associated with analgesic effect for more than 10 min. Clearance increases with decreasing age in children. The relationship between serum concentration and effect is poorly defined in children.
本研究旨在描述儿童氯胺酮的药代动力学,模拟时间-浓度曲线以预测与麻醉、苏醒和镇痛相关的浓度持续时间。
在急诊科接受疼痛治疗的儿童静脉注射氯胺酮1-1.5mg/kg。在随后的14-152分钟(中位数28.5分钟)内,3-6次(中位数3次)采集血液检测氯胺酮。采用非线性混合效应模型(NONMEM)进行群体药代动力学分析。使用模拟来预测该队列中的时间-浓度曲线。
对54名儿童(年龄8.3±3.5岁,体重32.5±15.6kg)进行了188次观察。二室(中央室、周边室)线性处置模型比一室模型更能拟合数据。使用异速生长模型将群体参数估计值及其个体间变异性(BSV)标准化至70kg个体,中央室容积(V1)为38.7(BSV 64%)L/70kg,周边室分布容积(V2)为102(51.7%)L/70kg,清除率(CL)为90(38.1%)L/h/70kg,室间清除率(Q)为215(19%)L/h/70kg。给予1mg/kg的儿童在10分钟时,一半儿童的血清浓度低于0.75mg/L。这是与成人“苏醒”相关的浓度。然而,几乎所有儿童的血清浓度仍高于0.1mg/L,这是与成人镇痛相关的水平。
静脉注射1mg/kg氯胺酮可为持续时间<5分钟的疼痛治疗的儿童提供满意的血清浓度,并产生与镇痛效果相关的浓度超过10分钟。儿童的清除率随年龄降低而增加。儿童血清浓度与效应之间的关系尚不明确。